FDA Brief

Warning letters Drugs

FDA warning letter to

Walfer Corporation dba The Medicine Shoppe Pharmacy

High riskIssued Sep 17, 2021Posted Oct 5, 2021Office of Pharmaceutical Quality Operations, Division II

FDA warned The Medicine Shoppe Pharmacy in Port Charlotte, Florida, over insanitary compounding conditions, vermin, and drugs made without valid prescriptions.

What happened

FDA investigators inspected the pharmacy from March 9 to March 16, 2020, and found dead ants on the production floor and dead cockroaches in a drawer next to the hood where drugs were made, plus stained equipment and damaged ceiling tiles. Investigators also found the firm compounded some drugs without valid prescriptions for individually identified patients. The firm recalled all of its drug products within expiry in March and April 2020 and said it no longer makes sterile products.

What FDA found

  1. The firm did not keep its buildings clean and free of insects and other pests.

    21 CFR 211.56(a)
  2. The firm did not clean and maintain its equipment and work surfaces well enough to prevent contamination.

    21 CFR 211.67(a)
  3. Ceiling tiles in the production area were unsealed, cracked and stained, including a brown water stain.

    21 CFR 211.56(a)
  4. Hazardous drugs were handled without adequate containment, separation or cleaning of surfaces and utensils, risking cross-contamination.

    21 U.S.C. § 351(a)(2)(A)
  5. Some drugs were compounded without valid prescriptions for individually identified patients, so they lost the exemption for compounded drugs.

    Section 503A of the FDCA [21 U.S.C. § 353a]
  6. The drugs' labeling lacked adequate directions for use because the conditions they treat cannot be safely self-diagnosed and treated by a layperson.

    Section 502(f)(1) of the FDCA [21 U.S.C. § 352(f)(1)]

What FDA wants

FDA asks the firm to write within 15 working days describing the specific steps taken to correct the violations, with supporting documentation such as cleaning logs and pest control records. The firm must also notify FDA 15 working days before resuming production of any sterile drugs.

Who should pay attention

  • pharmacies and prescribers that sent prescriptions to this compounding pharmacy
  • distributors and buyers that purchased its compounded drugs
  • other compounding pharmacies that handle hazardous drugs or sterile products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. CNC Noodle Corporation

    FDA warned CNC Noodle Corporation that its Hayward, California noodle plant had insanitary conditions, no pathogen or allergen controls, and mislabeled products.

    High risk
  2. ABC Food Corp

    ABC Food Corp's ready-to-eat rice noodles and tofu were made without required hazard analysis and preventive controls.

    High risk
  3. Rama Food Manufacture Corp.

    FDA warns Rama Food Manufacture after inspections found insanitary conditions and preventive-control failures at its California ready-to-eat rice noodle plants.

    High risk
  4. Lewis Sausage Company Inc.

    FDA found Salmonella and Listeria in contract-made pet food from Lewis Sausage and says its pathogen controls are inadequate.

    High risk